Bernard Beall, PhD

Director, Streptococcus Laboratory
Centers for Disease Control and Prevention

Disclosure: Nothing to disclose

Presentation(s):

• 85 - Characterization of Group B streptococcus Strains with Reduced Susceptibility to Beta-lactam Antibiotics, Active Bacterial Core Surveillance, 1998–2017

  Oral Abstract

• Impact of Pneumococcal Conjugative Vaccine on Antibiotic Resistant Invasive Pneumococcal Disease in the United States

  Thursday, October 22, 2020
  6:20pm – 6:30pm EDT